EDIT financials
Editas Medicine (EDIT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
EDIT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $40.52M | – | -$160.01M | -$160.06M | -1.80 |
| 2024 | $32.31M | – | -$251.15M | -$237.09M | -2.88 |
| 2023 | $78.12M | – | -$169.18M | -$153.22M | -2.02 |
| 2022 | $19.71M | – | -$225.95M | -$220.43M | -3.21 |
| 2021 | $25.54M | – | -$193.15M | -$192.50M | -2.85 |
| 2020 | $90.73M | – | -$134.84M | -$115.98M | -1.98 |
- EDIT revenue was $40.52M in fiscal 2025, net income -$160.06M.
Updated 2026-11-10 04:46 UTC